Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 991 results for "us food and drug administration"

Sterilisation deaths spotlight India drug safety record
The Malaysian Times

US FDA warns Indian agri-exporters

The US Food and Drug Administration (USFDA) has threatened to hold the consignments of Indian exporters selling agri-commodities at the US port if they fail to register with the administration by December 31. Business Standard, 4 days ago
Deaths put focus on India's drug sector Times Live South Africa, 12 hours ago
[x]  

256 images for us food and drug administration

Examiner.com, 4 days ago
Deutsche Welle, 3 days ago
Sky News Australia, 3 weeks ago
Proactive Investors USA, 1 week ago
Proactive Investors Australia, 1 week ago
Houston Chronicle, 4 days ago
AlterNet.org, 1 month ago
Reuters, 3 weeks ago
Yahoo! News, 3 weeks ago
Indian Express, 4 weeks ago
Business Today India

US FDA approves AZE Technology's Phoenix; a new concept for efficient, accurate image interpretation

The US Food and Drug Administration (FDA) has approved the AZE Technology's Phoenix (Volume Registration Viewer), a viewer developed with a completely new concept for efficient and accurate image interpretation. Phoenix is designed with background ...
 PharmaBiz1 day ago Ranbaxy sues over withdrawn US approvals  RSC2 days ago Ranbaxy sues US drug regulator for revoking approvals [India Business] [Times of India]  Pharmacy Choice2 days ago US court rejects Ranbaxy's plea over drug launch  Business Today India3 days ago
[x]  
Bidness Etc

Sanofi, Regeneron eczema drug gets FDA fast-track designation

PARIS, Nov 20 (Reuters) - Sanofi and its U.S. partner Regeneron said on Thursday the U.S. Food and Drug Administration had designated their dupilumab drug as "breakthrough therapy" in the treatment of atopic dermatitis, a chronic form of eczema, ...
 Yahoo! Finance3 days ago Sanofi SA (SNY), Regeneron Pharmaceuticals (REGN) Eczema Drug Gets FDA Breakthrough Therapy Designation  Bidness Etc3 days ago BrainStorm gets FDA fast-track status for ALS stem cell therapy  Reuters1 month ago
[x]  

Ranbaxy Laboratories files complaint against USFDA for revoking approved drugs

Ranbaxy Laboratories has filed a complaint against the US Food and Drug Administration (USFDA) in D.C. federal court and has also asked the Court for a temporary restraining order to prevent any further action by USFDA until Ranbaxy's case is ...
 Indian-Commodity4 days ago Ranbaxy files suit against USFDA for revoking approved drugs  DNA India4 days ago
Business Standard India

Sun Pharma recalls 68194 bottles of anti-depression drug in US

Report stated that company withdrew the drugs, after failed to dissolve properly, US Food and Drug Administration says. Sun Pharmaceuticals has recalled about 68,000 bottles of its anti-depressant venlafaxine hydrochloride, from the US market, says report.
 India Infoline5 days ago Sun Pharmaceutical : Third recall for Sun Pharma's Halol unit drug  4 Traders4 days ago Third recall for Sun's Halol unit drug  DNA India5 days ago Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Recalls 68,194 Bottles Of Anti-Depression Drug In U.S. 11/17/2014  ClinicSpace6 days ago
[x]  
Miami Herald

Maine risks losing funding over food stamp policy

AUGUSTA, Maine Gov. Paul LePage's administration is facing a potential loss of federal funding to administer its food stamp program over concerns about state's decision to put photos on cards used to access the benefits. Federal officials said ...
 FOXBusiness.com2 days ago US Federal Business Opportunity: Department of Health and Human Services: Notice of Intent to Sole Source- AccessMedicine & AcessPharmacy from McGraw Hil  ITbriefing1 day ago Feds threaten to pull funding for Maine food stamp program over concerns about photos on cards  Canadian Business Magazine2 days ago
[x]  
Pharmaceutical Technology

FDA grants orphan drug status for BerGenBio's BGB324 to treat acute myeloid leukaemia

The US Food and Drug Administration (FDA) has granted orphan-drug designation for Norwegian biopharmaceutical firm BerGenBio's BGB324 to treat acute myeloid leukaemia (AML). Recently, the company has also started a multi-centre Phase Ib trial of ...
 Pharmaceutical Business Review3 days ago Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Pemphigus  Street Sweeper2 days ago Janssen seeks FDA approval for its antipsychotic drug to treat schizophrenia  Pharmaceutical Technology3 days ago Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide TAF-Based Single Tablet Regimen for HIV  Pharmacy Choice4 days ago
[x]  

US FDA grants Breaktrough Therapy designation to atopic dermatitis drug, dupilumab

Regeneron Pharmaceuticals, and Sanofi announced that the US Food and Drug Administration (US FDA) has granted Breakthrough Therapy designation to dupilumab for the treatment of adults with moderate-to-severe atopic dermatitis (AD) who are not ...
 PharmaBiz2 days ago Sanofi and Regeneron's atopic dermatitis drug receives FDA breakthrough therapy status  Pharmaceutical Business Review2 days ago SANOFI : and Regeneron's atopic dermatitis drug receives FDA breakthrough therapy status  4 Traders2 days ago
Business Standard

Dr Reddy's launches allergy relief tablets in the US

as been approved by the United States Food & Drug Administration BS Reporter | Hyderabad November 20, 2014 Last Updated at 20:45 IST Hyderabad-based pharmaceutical company Dr Reddy’s Laboratories has launched over-the-counter (OTC) Fexofenadine ...
 Business Standard3 days ago Dr Reddy's announces launch of OTC tablets in US market  Business Standard India3 days ago Dr Reddy's launches OTC drugs in U.S. market  Hindu Business Line3 days ago Dr Reddy's announces launch of Sirolimus tablets  Myiris3 weeks ago

Bio Blast Pharma Ltd receives orphan drug designation from U.S. FDA for Cabaletta for the Treatment of Spinocerebellar Ataxia Type 3

9:15am EST Bio Blast Pharma Ltd:Announces that it has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for Cabaletta for the treatment of Spinocerebellar Ataxia Type 3.Says this is the second indication for which ...
 Reuters4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - us food and drug administration
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less